Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline

Radiofrequency ablation (RFA) is a new, minimally invasive modality that serves as an alternative to surgery in patients with thyroid tumors. The Task Force Committee of the Korean Society of Thyroid Radiology developed recommendations for the optimal use of RFA for thyroid tumors in 2012 and revise...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-hoon, Baek, Jung Hwan, Lim, Hyun Kyung, Na, Dong Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Ultrasound in Medicine 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443588/
https://www.ncbi.nlm.nih.gov/pubmed/30458605
http://dx.doi.org/10.14366/usg.18044
_version_ 1783407859006963712
author Kim, Ji-hoon
Baek, Jung Hwan
Lim, Hyun Kyung
Na, Dong Gyu
author_facet Kim, Ji-hoon
Baek, Jung Hwan
Lim, Hyun Kyung
Na, Dong Gyu
author_sort Kim, Ji-hoon
collection PubMed
description Radiofrequency ablation (RFA) is a new, minimally invasive modality that serves as an alternative to surgery in patients with thyroid tumors. The Task Force Committee of the Korean Society of Thyroid Radiology developed recommendations for the optimal use of RFA for thyroid tumors in 2012 and revised them in 2017. Herein, we review and summarize the 2017 thyroid RFA guideline and compare it with the 2012 thyroid RFA guideline.
format Online
Article
Text
id pubmed-6443588
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Ultrasound in Medicine
record_format MEDLINE/PubMed
spelling pubmed-64435882019-04-03 Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline Kim, Ji-hoon Baek, Jung Hwan Lim, Hyun Kyung Na, Dong Gyu Ultrasonography Review Article Radiofrequency ablation (RFA) is a new, minimally invasive modality that serves as an alternative to surgery in patients with thyroid tumors. The Task Force Committee of the Korean Society of Thyroid Radiology developed recommendations for the optimal use of RFA for thyroid tumors in 2012 and revised them in 2017. Herein, we review and summarize the 2017 thyroid RFA guideline and compare it with the 2012 thyroid RFA guideline. Korean Society of Ultrasound in Medicine 2019-04 2018-09-27 /pmc/articles/PMC6443588/ /pubmed/30458605 http://dx.doi.org/10.14366/usg.18044 Text en Copyright © 2019 Korean Society of Ultrasound in Medicine (KSUM) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kim, Ji-hoon
Baek, Jung Hwan
Lim, Hyun Kyung
Na, Dong Gyu
Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title_full Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title_fullStr Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title_full_unstemmed Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title_short Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
title_sort summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443588/
https://www.ncbi.nlm.nih.gov/pubmed/30458605
http://dx.doi.org/10.14366/usg.18044
work_keys_str_mv AT kimjihoon summaryofthe2017thyroidradiofrequencyablationguidelineandcomparisonwiththe2012guideline
AT baekjunghwan summaryofthe2017thyroidradiofrequencyablationguidelineandcomparisonwiththe2012guideline
AT limhyunkyung summaryofthe2017thyroidradiofrequencyablationguidelineandcomparisonwiththe2012guideline
AT nadonggyu summaryofthe2017thyroidradiofrequencyablationguidelineandcomparisonwiththe2012guideline

Ejemplares similares